On August 15, 2023, the Minister of Health announced the appointment of Anie Perrault as Vice Chairperson of the Patented Medicine Prices Review Board (PMPRB) for a five-year term. According to the announcement, Ms. Perrault has over 30 years of experience in the public and private sectors, having held positions in the genomic research and biotechnology sector in Quebec and nationally.
On August 22, 2023, the PMPRB published the seventh edition of its annual Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries. The 2023 report examines trends in new medicine approvals and sales internationally and in Canada from 2016-2021, with a focus on medicines approved in 2020 and 2021.
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.